I think people must just be realising the high probability of...

I think people must just be realising the high probability of Ph2b success. Next SAS read-out is surely the nail in the coffin. Dosage and protocols very similar to trial so you'd expect results to be the same. Huge market, it works, reduces requirement for steroids as well as opiates. You'd expect a successful trial result to be shortly followed by partnership (milestone payments and ongoing royalties), or a straight takeover at huge premiums. No shares will be leaving my account until all the cards are on the table. Potential upside is just too tempting to not be all in. All IMO